View Press Releases
-
Linguamatics Highlights 2018 Achievements and Advances NLP Text Analytics Market Leadership
CAMBRIDGE, N/A, UNITED KINGDOM - Dec 12, 2018 - In 2018, Linguamatics advanced its position as the market-leading provider of natural language processing (NLP) text analytics for healthcare and the life sciences, winning prestigious industry awards, introducing innovative product enhancements, and partnering with organizations to extend the value of Linguamatics solutions
Dec 12, 2018
-
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD
STOCKHOLM, SWEDEN - Dec 12, 2018 - Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market
Dec 12, 2018
-
Creative Diagnostics Introduces Cytotoxic Drug Antibodies for Science Community
SHIRLEY, NY, UNITED STATES - Dec 13, 2018 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics is proud to announce that it has launched a new set of antibodies specific to cytotoxic drugs for life science community facing the growing challenges for scientific research
Dec 11, 2018
-
Rho Announces New Regulatory Strategy and Submissions Business Segment
CHAPEL HILL, NC, UNITED STATES - Dec 10, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced a new Regulatory Strategy and Submissions business segment
Dec 11, 2018
-
FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery with Geneious Biologics
AUCKLAND CITY, NEW ZEALAND - Dec 10, 2018 - AUCKLAND, NZ – December 10, 2018 – Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the companys growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs
Dec 10, 2018
-
Qlucore announces partnership with Cambridge Protein Arrays Ltd
GUILDFORD, UNITED KINGDOM - Dec 10, 2018 - The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysis
Dec 10, 2018
-
HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for Cancer
CAMBRIDGE, MA, UNITED STATES - Dec 10, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, today announced the formation of Victa Biotherapeutics, a joint venture with Vikas P
Dec 10, 2018
-
10x Genomics Acquires Spatial Transcriptomics
PLEASANTON, CA, UNITED STATES - Dec 10, 2018 - 10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics
Dec 10, 2018
-
Rho Experts Explore Right-to-Try Legislation and Existing Expanded Access Programs in Free Webinar
CHAPEL HILL, NC - Dec 7, 2018 - Rho Experts Explore Right-to-Try Legislation and ExistingExpanded Access Programs in Free Webinar WHAT: The impact of Right-to-Try legislation has been in the news a lot recently, but what does the legislation mean for product sponsors? Rho, a full-service contract research organization (CRO), will explore both Right-to-Try legislation and existing Expanded Access Programs in a new free webinar, including:o Understanding sponsor responsibilities under these programs and when products may be eligibleo Evaluating options such as treatment protocols, treatment INDs, and emergency useo Discussing development risks associated with participation in these programs The webinar, "Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA's Expanded Access," will take place on Tuesday, Dec
Dec 7, 2018
-
Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity
PLYMOUTH MEETING, PA - Dec 6, 2018 - Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent)
Dec 6, 2018
-
Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research Centers
RANCHO SANTA MARGARITA, CA, UNITED STATES - Dec 4, 2018 - Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research CentersCutting Edge Data Quality Transforms Real-World Clinical Data into aFuture-Proofed, Research-Ready Data Goldmine for Better Patient CareMelissa, a leading provider of global contact data quality and identity verification solutions, today announced advanced artificial intelligence (AI) solutions that combine machine reasoning, natural language processing, and machine learning to tackle one of healthcare's biggest problems: the time and cost of data harmonization and integration
Dec 5, 2018
-
Equus Compute Solutions Announces Release of G2660 2U 2xGPU Server
EDINA, MN - Dec 5, 2018 - Equus Compute Solutions announces the release of its new G2660 2U 2xGPU server, ideal for artificial intelligence and deep learning environments
Dec 5, 2018
-
Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)
KANSAS CITY, KS, UNITED STATES - Dec 5, 2018 - Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry
Dec 5, 2018
-
Certara Launches BaseCase Toolkits to Facilitate Pharmaceutical and Medical Device Field Teams’ HCP and Payer Presentations
PRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations
Dec 5, 2018
-
uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target
EDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target
Dec 5, 2018
-
BOC Sciences Recently Updates Its Metabolites and Impurities Collection
LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research community
Dec 3, 2018
-
Creative Peptides Released Post-translational Modification for Science Community
LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the worlds leading peptide manufacturers, has announced a series of peptide modification services
Dec 3, 2018
-
TARGET PharmaSolutions® Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research
CHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD
Dec 3, 2018
-
MDI Biological Laboratory Scientist Receives Scientific Innovation Award
BAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund
Nov 30, 2018
-
Greenphire Named to Deloitte's 2018 Technology Fast 500™ for Fifth Consecutive Year
KING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500
Nov 30, 2018